Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

PMCB Stock Forecast, Price Targets, Chart, Dividends & Analysis

PharmaCyte Biotech Inc logo

PharmaCyte Biotech Inc

Sector: Healthcare   

Industry: Biotechnology

1.64
 
USD
  
0.00
  
(0.00%)
Previous close: 1.64  Open: 1.64  Bid: 1.63  Ask: 1.7
52 week range    
1.39   
   2.58
Mkt Cap: 12 M  Avg Vol (90 Days): 33,844
Peers   
PAHC / 
USNA / 
NATR / 
Last updated: Monday 23rd December 2024

Stock Rankings

43
MarketXLS Rank
80
Value
23
Technical
28
Quality
How are these ranks calculated?
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

MTEX

0 B-1911.87

NATR

0 B17.6415

PAHC

0.02211 B52.6521.69

USNA

1 B12.9733.38
Financials

PMCB Income Statement

Annual
Apr-14Apr-16Apr-17Apr-18Apr-19Apr-20Apr-21Apr-22Apr-23Apr-24
AccretionOnPreferredStock15 M
AccruedPreferredStockDividends3 M
AcquisitionExpense406812.0
Amortization of intangibles406812.0
Basic EPS from continuing operations-2.45-0.27-0.22-1.8
Basic EPS total-75.0-2.45-0.27-0.22-1.8
Basic weighted shares outstanding388813.0501602.0563539.0645761.0733402.0903811.01 M16 M19 M10 M
CommissionExpenses768000.0
Depreciation unreconciled406812.0
DepreciationAndAmortization406812.0
DevelopmentExpense65500.0
Diluted EPS total-15.0-15.0-15.0-2.45-0.27-0.22-1.8
Diluted normalized net income/share-0.27-0.22-1.8
Diluted weighted shares outstanding388813.0501602.0563539.0645761.0733402.0903811.01 M16 M19 M10 M
Earnings from equity interest5876.0
EarningsFromEquityInterestNetOfTax5876.0
Fees-45000.0
GainOnSaleOfPPE-2 M
GeneralAndAdministrativeExpense3 M3 M1 M2 M2 M2 M1 M2 M5 M5 M
Income before tax-29 M-6 M-4 M-7 M-4 M-4 M-4 M-4 M-4 M-7 M
Income taxes-2 M-195211.0-887749.0-6454.0-803646.0-745760.0-890224.0-906359.0
Interest income1090.0157645.02 M3 M
InterestExpenseNonOperating19963.01191.01539.0453.03046.0509.0
InterestExpenseOperating45000.0
MarketingExpense65500.0326540.0
MiscOtherSpecialCharges-10 M10540.0-1539.0152588.033401.0-40.074791.0-4283.0202002.0191145.0
Net income from total operations-27 M-6 M-4 M-7 M-4 M-4 M-4 M-4 M-4 M333763.0
NetIncomeCommonStockholders-27 M-6 M-4 M-7 M-4 M-4 M-4 M-4 M-4 M-17 M
NetIncomeContinuousOperations-27 M-6 M-4 M-7 M-4 M-4 M-4 M-4 M-4 M333763.0
NetNonOperatingInterestIncomeExpense-19963.0-1191.0-1539.0-453.0-3046.0157136.02 M3 M
Normalized income-4 M-5 M-3 M
Operating income-18 M-6 M-4 M-7 M-4 M-4 M-4 M-4 M-6 M-9 M
Operating income before depreciation (EBITDA)-29 M-6 M-4 M-7 M-4 M-4 M-4 M-4 M-5 M333763.0
OperatingExpense-19 M-6 M-4 M-7 M-4 M4 M4 M4 M6 M9 M
Other income net11 M-10540.01539.0-152588.0-33401.040.0-74791.0-4283.0-202002.03 M
OtherGandA3 M3 M1 M2 M2 M2 M1 M2 M5 M5 M
OtherImpairmentOfCapitalAssets2 M
OtherOperatingExpenses-19 M-6 M-4 M30964.020429.019341.023420.029546.0
OtherWriteDown768000.0326540.0
OtherunderPreferredStockDividend18 M
PreferredStockDividends18 M
RentAndLandingFees2 M2 M744796.02 M1 M
Research & development expense323500.01 M1 M2 M460052.0301221.0916249.0690937.0468536.0407431.0
ResearchExpense323500.01 M1 M2 M460052.0301221.0916249.0690937.0468536.0407431.0
Revenue per share406812.0
SalariesAndWages14 M2 M2 M2 M2 M2 M1 M2 M1 M1 M
Selling Gen & administrative expense4 M3 M1 M3 M2 M2 M1 M2 M5 M5 M
SellingAndMarketingExpense872200.065500.0326540.0
SellingExpense872200.0
Total Income available for interest expense (EBIT)-29 M-6 M-4 M-7 M-4 M-4 M-4 M-4 M-5 M333763.0
Total common shares outstanding472837.0565369.0648778.0694025.0885447.02 M2 M21 M9 M8 M
Total net income-27 M-6 M-4 M-7 M-4 M-4 M-4 M-4 M-4 M333763.0
Total ordinary shares8 M8 M8 M8 M8 M8 M8 M8 M8 M8 M
TotalExpenses-19 M-6 M4 M-7 M-4 M4 M4 M4 M6 M9 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University